The startup offers an automated protein manufacturing system that enables users to produce biologics efficiently and cost-effectively. This technology addresses the lengthy development cycles and high costs associated with creating new medicines and bio-based products.
Funding
$3.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
SBFounders
Product
Problem
Traditional protein production methods are capital-intensive, involve complex development processes, and often require large-scale, single-product manufacturing facilities. This makes it difficult for researchers and developers to efficiently produce proteins for new medicines, food products, and other bio-produced products. Conventional protein production also requires a skilled workforce, creating a barrier to entry for many innovators.
Solution
Sunflower Therapeutics offers next-generation protein manufacturing solutions designed for ease of use and broad accessibility. Their automated and fully-integrated platform simplifies the entire biomanufacturing process, from discovery and development to full-scale production. The company's perfusion fermentation technology allows for continuous feeding of biomass, harvesting of fluids, and retention of cells within a controlled bioreactor environment. This in-vessel perfusion strategy results in healthier cell cultures, longer production campaigns, ultra-high cell mass, and high protein yields. Sunflower Therapeutics' solutions reduce barriers to protein manufacturing, enabling researchers and developers to achieve faster results with fewer resources.
Target Audience
The primary target audience includes researchers and developers in drug/vaccine development, food technologies, synthetic biology, and diagnostics, as well as startups and established companies seeking to streamline protein production.
Features
- Daisy Petal™ Perfusion Bioreactor System: A benchtop automated single-use bioreactor system for continuous protein, molecule, or cell line production using microbes.
- Dahlia Petal™ Perfusion Bioreactor System: A larger microbial perfusion fermentation system designed for process scale-up from the Daisy Petal™ system.
- HelianthOS™: A universal operating system that automates all parameters during fermentation, reducing the need for manual supervision.
- Nursery™: A cloud-based application for developing fermentation recipes and documenting process fluids.
- Harvest™: A software tool for secure storage and retrieval of data collected during bioprocessing campaigns, designed to meet 21 CFR Part 11 standards.
- Patented in-vessel cell retention device for perfusion or chemostat fermentations.
- Structured single-use bioreactor assembly for easy and reliable installation.
- Ready-to-use sensors for pH, dissolved oxygen, temperature, and offgas monitoring.
- Capability to scale up continuous processes instantly from Daisy Petal™ to Dahlia Petal™.